3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Hodgkin Disease
5
Lymphoma
4
Recurrence
3
Lymphoma, T-Cell
3
Lymphoma, Follicular
3
Uveal Melanoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Glioblastoma
2
Burkitt Lymphoma
2
Vasculitis, Central Nervous System
1
Stiff-Person Syndrome
1
Rasmussen subacute encephalitis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Plasmablastic Lymphoma
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Opsoclonus-Myoclonus Syndrome
1
Oligodendroglioma
1
Neuromyelitis Optica
1
Neoplasms
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
Cyclophosphamide
6
Vincristine
3
Temozolomide
3
Radiotherapy
3
Cisplatin
3
Automobiles
3
fludarabine
2
Etoposide
2
Eflornithine
2
Carboplatin
2
omburtamab I-131
1
ibrutinib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy, Image-Guided
1
Pemetrexed
1
ONC206
1
Nivolumab
1
Mesna
1
Maintenance Chemotherapy
1
Lomustine
1
Isotretinoin
1
Induction Chemotherapy
1
Hydrocortisone
1
HhAntag691
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Carmustine
×
1 year
×
Clear all
No trials found.